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Brain function depends on co-ordinated transmission of signals from both excitatory
and inhibitory neurotransmitters acting upon target neurons. NMDA, AMPA and mGluR
receptors are the major subclasses of glutamate receptors that are involved in excitatory
transmission at synapses, mechanisms of activity dependent synaptic plasticity, brain
development and many neurological diseases. In addition to canonical role of regulating
presynaptic release and activating postsynaptic potassium channels, GABAB receptors
also regulate glutamate receptors. There is increasing evidence that metabotropic
GABAB receptors are now known to play an important role in modulating the excitability
of circuits throughout the brain by directly influencing different types of postsynaptic
glutamate receptors. Specifically, GABAB receptors affect the expression, activity and
signaling of glutamate receptors under physiological and pathological conditions.
Conversely, NMDA receptor activity differentially regulates GABAB receptor subunit
expression, signaling and function. In this review I will describe how GABAB receptor
activity influence glutamate receptor function and vice versa. Such a modulation
has widespread implications for the control of neurotransmission, calcium-dependent
neuronal function, pain pathways and in various psychiatric and neurodegenerative
diseases.
Keywords: glutamate receptor, NMDAR, GABABR, AMPAR, AKAP, receptor regulation, receptor trafficking and
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Introduction
Most excitatory signals that a neuron receives are mediated via glutamate receptors whereas most
inhibitory signals are mediated via γ-aminobutyric acid (GABA) receptors (Cherubini et al.,
1991; Hollmann and Heinemann, 1994). Many factors influence the regulation of excitatory
and inhibitory synaptic inputs on a given neuron. One important factor is the subtype of
neurotransmitter receptors present at not only the correct location to receive the appropriate
signals but also their abundance at synapses (Dingledine et al., 1999; Sheng and Kim, 2011). Thus
the molecular mechanisms that regulate receptor expression and localization at specific sites are
of considerable importance. This review will describe the recent advances in our understanding of
the molecular mechanisms underlying glutamate and GABAB receptors cross-talk and discuss the
roles of specific proteins that might control these processes.
Glutamate receptors are the major excitatory neurotransmitter receptors in the brain
and play an important role in neural plasticity and development. Improper function of
glutamate receptors is involved in various psychiatric and neurodegenerative diseases
(Mattson, 2008; Musazzi et al., 2013). N-methyl-D-aspartate receptors (NMDARs), α-amino-
3-hydroxy-5-methyl-4-isoxazolepropionate receptors (AMPARs) and kainate receptors are
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glutamate-gated ion channels, whereas metabotropic glutamate
receptors (mGluRs) are G-protein-coupled receptors (GPCRs)
that signal downstream via interaction with heterotrimeric G-
proteins. Pharmacological and molecular biological studies have
revealed that glutamate receptors exist as different subclasses,
where receptor subtypes comprise multiple subunits such as
NMDA receptors (GluN1 to GluN3), AMPA receptors (GluA1 to
GluA4), kainate receptors (GluK1 to GluK5) and mGlu receptors
(mGluR1 to mGluR8) (for reviews, see Nakanishi et al., 1998;
Lodge, 2009; Nicoletti et al., 2011).
Conversely, GABA receptors are the primary proteins
responsible for inhibitory responses in the brain. Metabotropic
GABA receptors (GABABRs) are GPCRs that can mediate
slow inhibitory neurotransmission in the CNS. GABABRs are
located at both presynaptic and postsynaptic compartments
and changes in their number, localization and activity affect
the level of synaptic inhibition. Presynaptic GABABRs inhibit
release of neurotransmitter by inhibiting Ca2+ channels (Wu and
Saggau, 1995; Takahashi et al., 1998). Activation of postsynaptic
GABABRs activates inwardly rectifying K+ channels (GIRK)
to generate slow inhibitory postsynaptic potentials (reviewed
in Marshall et al., 1999; Bowery et al., 2002; Gainetdinov
et al., 2004). The GABABR is a heteromeric GPCR consisting
of GABAB1 and GABAB2 subunits that exert much longer
lasting synaptic inhibition compared to GABAA ion channels
(Marshall et al., 1999; Watanabe et al., 2002). The ligand-
binding domain (Malitschek et al., 1999) is present in GABAB1
subunit and G-proteins interact with GABAB2 to regulate
adenylate cyclase, GIRK channels and Ca2+ channels (Robbins
et al., 2001). A large body of work over the last 20 years
has demonstrated that GABAB receptors are regulated via
mechanisms distinct from those utilized by many classical
GPCRs such as the β2-adrenergic receptor (Bettler and Tiao,
2006). For example, following agonist exposure most GPCRs
are phosphorylated and endocytosed from the cell surface into
intracellular compartments and then either down-regulated via
lysosomal or proteasomal degradation or recycled back to the
cell surface following agonist removal. In contrast, cell surface
GABAB receptor levels are not significantly altered upon receptor
stimulation in cultured cortical and hippocampal neurons
(Fairfax et al., 2004; Bettler and Tiao, 2006). GABAB receptors
are very stable at the plasma membrane even after agonist
exposure with little internalization in cultured neurons. The
absence of receptor endocytosis correlates with lack of arrestin
recruitment and agonist-induced phosphorylation (Fairfax et al.,
2004). Surprisingly, increased phosphorylation at serine 892
in GABAB2 subunit decreased degradation rates and stabilizes
surface GABABRs in neurons (Couve et al., 2004; Fairfax et al.,
2004).
The main regulatory sites on both glutamate receptors and
GABABRs are their intracellular C-terminal tails. Depending
on the activity or stimulation received by the receptors, the C-
terminal domains bind to various proteins including enzymes,
scaffolds, and trafficking and signaling proteins (De La Rue
and Henley, 2002). These sites sometimes also mediate complex
formation during a cross-talk between the receptors. Many
immunocytochemical and electron microscopy studies have
demonstrated that glutamatergic synapses are enriched with
GABABRs (Fritschy et al., 1999; Luján and Shigemoto, 2006).
There is also increasing evidence that NMDARs, AMPARs and
mGluRs are modulated directly and sometimes indirectly by
GABABRs (Morrisett et al., 1991; Hirono et al., 2001; Otmakhova
and Lisman, 2004; Tabata et al., 2004; Sun et al., 2006; Chalifoux
and Carter, 2010; Gandal et al., 2012; Terunuma et al., 2014).
Conversely, GABABR subunits are differentially regulated by
glutamate receptor subtypes under various stimulation protocols
(Vargas et al., 2008; Cimarosti et al., 2009; Guetg et al.,
2010; Maier et al., 2010; Terunuma et al., 2010; Kantamneni
et al., 2014). The sections below in this review will follow
this theme of regulation or modulation between GABAB
and glutamate receptors. This cross-talk provides important
regulatory mechanisms, for example, in altering presynaptic
release or changes to membrane potential, but also alters the
function of glutamate receptors, which may prove useful in a
therapeutic context.
GABABR-Mediated Regulation of
Glutamate Receptor Function
GABABR Regulation of NMDAR-Dependent
Post-Synaptic Calcium Signals
The major synaptic Ca2+ signals in the brain are mediated via
NMDARs, which are crucial for activity-dependent changes in
synaptic plasticity (Bliss and Collingridge, 1993; Mainen et al.,
1999;Malenka and Bear, 2004). These Ca2+ signals are thought to
be inhibited by GABAB receptors via modulation of K+ channels,
resulting in a hyperpolarization that decreases the Ca2+ influx
and overall current by enhancing Mg2+ blockade of NMDARs.
(Morrisett et al., 1991; Otmakhova and Lisman, 2004; Deng
et al., 2009). Interestingly, it has also been demonstrated recently
that Ca2+ influx via NMDARs is inhibited by GABAB receptor
activation (Chalifoux and Carter, 2010). This effect on NMDARs
is independent of K+ channel and voltage sensitive Ca2+ channel
activation, Gβγ subunits and internal Ca2+ stores. Via coupling
to Gαi/Gαo G proteins, GABABRs inhibit adenylate cyclase to
reduce PKA activity by decreasing cAMP levels. The Ca2+ influx
via NMDA receptors is normally increased by PKA activity and
reduction of PKA activity by GABABRs inhibits Ca2+ signals
(Chalifoux and Carter, 2010). GABABR-mediated postsynaptic
modulation through the PKA pathway does not affect synaptic
currents mediated by NMDA or AMPA receptors (Chalifoux
and Carter, 2010). As outlined below, protein kinases such as
PKA and phosphatases such as PP1/2 and calcineurin (CaN) are
regulated via AKAPs (AKinase Anchoring Proteins) andmediate
signaling where they act as scaffold molecules (see below for
further insights).
NMDAR and GABABR Cross-Talk in Disease
Recently it has been demonstrated that, there is clear interplay
between GABAB and NMDA receptors not only in physiological
functions but also in pathological situations. Altered NMDAR
activity is observed in models of pain and neuropsychiatric
disorders, but an interesting phenomenon is that these
phenotypes can be rescued with GABABR ligands. For example,
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in diabetic neuropathy, NMDAR expression is increased in spinal
cord dorsal horn, while GABAB receptors are down regulated
at protein level (Wang et al., 2011). Using streptozotocin
(STZ)-induced diabetic neuropathy rat models (STZ), it has
been found that intrathecal injection of the GABABR agonist
baclofen significantly increased paw withdrawal threshold.
This effect was blocked with pre-treatment of CGP55845, a
GABABR—selective antagonist (Bai et al., 2014). In STZ rats,
changes in expression were observed in both cyclic AMP
response element-binding protein (CREB) and GluN2B, which
were significantly increased at the protein (CREB and GluN2B)
and mRNA level (GluN2B) in spinal cord. The higher expression
levels of both GluN2B and phosphorylated CREB proteins were
significantly reduced by administration of baclofen (Liu et al.,
2014). Importantly, baclofen-induced reduction of GluN2B and
CREB expression was abolished when CGP55845 was pre-
administered, suggesting that GABABR activation in the spinal
cord dorsal horn can normalize NMDAR expression levels in
diabetic neuropathic pain (Wang et al., 2011; Bai et al., 2014; Liu
et al., 2014).
In contrast, reduced NMDA receptor functionality has been
observed in neuropsychiatric disorders like intellectual disability,
autism and schizophrenia (Gonda, 2012). For example, a
mouse model expressing a reduced amount of GluN1 subunit
(NR1neo−/− mice) was characterized to mimic schizophrenic-
like behavior (Mohn et al., 1999). These mice have increased
power in the gamma (30–80Hz) EEG range during rest, but show
a reduced auditory-stimulus evoked gamma power (reduced
gamma signal-to-noise), causing changes in excitatory/inhibitory
balance, and express treatment resistant symptoms of autism
and schizophrenia (Gandal et al., 2012). Treating NR1neo−/−
mice with baclofen restored excitatory/inhibitory balance,
neural synchrony and also improved social function and
spatial memory deficits (Gandal et al., 2012). To summarize,
diseases characterized by NMDA receptor dysfunction, have
the additional possibility of using GABAB receptors as an
appropriate target for therapy that could possibly pave the way
to restore abnormalities in many other neurological diseases.
GABABR Cross-Talk with AMPARs
Surface expression of AMPA receptors was increased in a
knock-in mouse model in which wild-type GABAB2R was
replaced with a S783A-mutated version which cannot be
phosphorylated (Terunuma et al., 2014). The S783 on GABAB2
subunit is phosphorylated by AMP-dependent protein kinase
(AMPK), which in-turn enhances receptor coupling to GIRKs
(Kuramoto et al., 2007). Activating NMDARs transiently
results in increased phosphorylation whereas prolonged
activation results in dephosphorylation of GABABRs by protein
phosphatase 2A (PP2A). GABABRs stability at cell surface
is due to high constitutive phosphorylation of GABAB2R
and dephosphorylation of this subunit selectively targets the
receptors for lysosomal degradation (Fairfax et al., 2004;
Terunuma et al., 2010). The expression of GABABR was
increased with the mutation due to reduced degradation,
leading to decreased level of Arc/Arg3.1 protein necessary for
memory consolidation. This, in turn, increased the number of
excitatory synapses, PSD95 protein expression and cell surface
AMPA receptors. This cross-talk demonstrates a crucial role for
GABABRs in regulating excitatory synaptic transmission and
neuronal architecture (Terunuma et al., 2014).
GABABR Cross-Talk with mGluRs
Long-term depression (LTD) at cerebellar parallel fiber Purkinje
cell synapses is a form of synaptic plasticity critical for
cerebellar motor learning and requires the activation of the
metabotropic glutamate receptor mGluR1 (Ichise et al., 2000;
Ito, 2001). GABABRs are concentrated at cerebellar parallel
fiber Purkinje cell synapses and have many functions that are
both dependent and independent of GABA. GABABRs and
mGluR1 are highly co-expressed in cerebellar Purkinje cells,
and display very similar subcellular localizations throughout
development (Ige et al., 2000; Luján and Shigemoto, 2006;
Rives et al., 2009). Electrophysiological studies have shown
that at Purkinje cell synapses, GABABR activation inhibits
neurotransmitter release by inhibiting calcium channels as
well as affecting release processes (Dittman and Regehr, 1996,
1997; Vigot and Batini, 1997). Extracellular Ca2+ interacts with
GABABR in cerebellar Purkinje cells, leading to an increase
in the glutamate sensitivity of mGluR1. This sensitization of
mGluR1 to glutamate is specifically mediated by GABABRs as
it is absent in cells from GABAB1−/− animals. It has also been
shown that both GPCRs form a complex in cerebellum and
that extracellular Ca2+-mediated crosstalk is not mediated via
Gi/o proteins (Tabata et al., 2004). Activity-dependent GABABR
inhibition by selective antagonists reduces the magnitude
of LTD at parallel fiber Purkinje cell synapses (Kamikubo
et al., 2007; Rives et al., 2009). In summary GABABRs not
only mediate classical synaptic GABAergic neurotransmission
but also regulate mGluR signaling and cerebellar synaptic
plasticity.
NMDAR-Mediated Regulation of GABABR
Function
GABABRs are very stable at cell surface in terms of agonist
stimulation and the number of cell surface GABABRs is primarily
controlled by glutamate and not GABA in central neurons
(Fairfax et al., 2004; Vargas et al., 2008). Sustained application of
glutamate leads to GABABR endocytosis, trafficking to lysosomes
and subsequent degradation, resulting in a decrease in receptor
expression at the cell membrane (Vargas et al., 2008; Maier et al.,
2010). Further dissection of the effect of glutamate indicated that
activation of AMPA and NMDA receptors is required for the
down-regulation of GABABRs and that this effect is enhanced by
activation of the group I mGluRs (mGlu1 and mGlu5) (Maier
et al., 2010). Activation of NMDARs alone leads to down-
regulation and degradation of GABAB1 and GABAB2 subunits,
thereby reducing cell surface expression (Guetg et al., 2010;
Terunuma et al., 2010; Kantamneni et al., 2014). Mechanistically,
NMDAR activation triggers GABAB1 subunit phosphorylation
on Ser867 by CaMKII, causing a CaMKII-dependent down
regulation (Guetg et al., 2010). In both hippocampal and
cortical cultured neurons NMDAR activation also alters the
Frontiers in Cellular Neuroscience | www.frontiersin.org 3 April 2015 | Volume 9 | Article 135
Kantamneni Glutamate and GABAB receptors cross-talk
phosphorylation state of GABAB2 subunit on Ser783, resulting in
endocytosis and lysosomal degradation of the receptor complex
(Terunuma et al., 2010). The GABAB2 subunit is also rapidly
phosphorylated by AMPK upon NMDAR activation. Prolonged
NMDAR activation subsequently results in GABAB2 subunit
dephosphorylation by PP2A, which decreases the number of cell
surface receptors (Terunuma et al., 2010).
Recently it has been shown that selective activation of
synaptic NMDARs using chemically induced LTP (long-term
potentiation) protocol (chem-LTP) leads to an increase in surface
GABAB receptors (Kantamneni et al., 2014). In the chem-LTP
protocol, glycine (along with strychnine and bicuculline—to
block glycine and GABAA receptors, respectively) was used to
specifically activate synaptic NMDARs, leading to significant
increase in surface expression of AMPARs (Lu et al., 2001; Park
et al., 2004). Prolonged activation of extrasynaptic NMDARs
promotes cell death, whereas activation of synaptic NMDARs
mediates synaptic plasticity and is thought to be involved
in neuroprotection via modulation of nuclear Ca2+ signaling
(Hardingham and Bading, 2010). Using the chem-LTP method,
both GABAB1 and GABAB2 receptor subunit expression on the
cell surface were increased in cultured rat hippocampal neurons
due to enhanced receptor recycling from intracellular pools
(Kantamneni et al., 2014).
GABABR subunits are differentially regulated under
oxygen/glucose deprivation (OGD) conditions, which stimulates
release of excess glutamate resulting in excitotoxic activation
of NMDARs (Papadia and Hardingham, 2007; Cimarosti et al.,
2009; Kantamneni et al., 2014). After OGD, expression of
GABAB1 subunits at the cell surface is increased via enhanced
recycling, while total cellular and cell surface expression
levels of GABAB2 subunits are decreased due to reduced
recycling (Cimarosti et al., 2009; Kantamneni et al., 2014;
Maier et al., 2014). Removing GABAB2 subunit will decrease
the number of functional GABABRs, as both subunits are
required for normal signaling. In conclusion, the above findings
demonstrate that the expression and regulation of GABABR
subunits are dynamically regulated in response to synaptic and
prolonged/global stimulation of NMDARs. Moreover, NMDAR
regulation of GABABRs may be important under conditions of
neurological disease, such as epilepsy or ischemia.
Anchoring and Scaffold Proteins as
Possible Mediators of GABA/Glutamate
Receptor Cross-Talk
Both GABAergic and glutamatergic receptor complexes are
regulated and orchestrated by anchoring and scaffold proteins,
which are increasingly being implicated in the cross-talk between
the two systems. Components of receptor signalosome are
typically localized together via scaffold proteins, which co-
assemble receptors with regulatory proteins such as protein
kinases and phosphatases. AKAPs are typical examples of
this class of scaffold proteins (Wong and Scott, 2004). For
example, AKAP5 (or AKAP79/150) is thought to localize PKA,
protein kinase C (PKC) and the calmodulin-activated protein
phosphatase calcineurin (CaN) at specific synaptic sites to
regulate excitatory synaptic strength (Gomez et al., 2002; Smith
et al., 2006; Robertson et al., 2009; Jurado et al., 2010). AKAP5 is
linked to NMDARs via PSD-95 (Colledge et al., 2000). AKAP5
is known to be a master scaffolding protein that links many
proteins including kinases, phosphatases, cadherins, F-actin,
MAGUKs and PIP2 together with ion channels and receptors
to regulate activity dependent signaling processes at synapses
(Tunquist et al., 2008; Sanderson and Dell’Acqua, 2011). Many
of the proteins binding to AKAP5 (such as PKA, PP2B) also
regulate GABABRs and perhaps there is possibility that AKAP5
scaffolding function may be required for glutamate/GABA
receptors cross-talk.
Yotiao is another AKAP protein derived from alternative
splicing of AKAP9 (also known as AKAP350/450) and plays a
major role in regulating NMDARs. Yotiao was first identified as
a binding partner of the GluN1 subunit and later found to be
an AKAP via its ability to bind PKA-RII subunits in vitro (Lin
et al., 1998; Westphal et al., 1999). Yotiao binds both protein
phosphatase 1 (PP1) and PKA to form a phosphatase-kinase
signaling complex with the GluN1A receptor splice variant.
The Yotiao-PP1-PKA complex functions as dual switch, in that
activation of anchored PKA enhances NMDAR currents while
activation of PP1 exerts an inhibitory effect on NMDAR activity
(Westphal et al., 1999; Colledge et al., 2000).
GABAB1Rs were previously shown to interact with a
scaffold protein, GISP that enhances cell surface expression
of heteromeric complex GABAB1/GABAB2 (Kantamneni et al.,
2007). GISP is an AKAP9 C-terminal splice variant with more
than 90% similarity to AKAP9 but lacking any RII domain,
which are PKA binding sites (Kantamneni et al., 2007). As
mentioned previously, the NMDAR binding protein Yotiao is
also an AKAP9 splice variant, but within the N-terminal region.
Therefore, theoretically, AKAP9 could interact simultaneously
with NMDARs and GABABRs as well as regulatory protein
kinases and phosphatases. Thus, while speculative, it is tempting
to suggest that AKAP9 functions to assemble the signaling
complex responsible for mediating the observed cross-talk
between the NMDARs and GABABRs. From expression studies
it is known that AKAP9 is expressed in the brain and localized
to synapses (Collado-Hilly and Coquil, 2009). In similarity to
the AKAP5-CaN_PP2B-PKA complex, the AKAP9-PKA-PP1
complex might exist as one large macromolecular complex held
together with receptor proteins such as GABABRs andNMDARs.
At least in yeast-two hybrid assay it has been confirmed that GISP
does not interact with NMDAR sub-type 1 (Kantamneni et al.,
2007). GISP binding to other subtypes of NMDARs or Yotiao
binding to GABABRs has not been tested, and that this warrants
further work. Another protein that may potentially mediate
direct crosstalk between GABABR signaling and glutamate
receptor signaling is CaMKII. CaMKII is a Ca2+ calmodulin
dependent protein kinase, previously been shown to interact
with both GABAB and NMDA receptors and regulate NMDAR
mediated plasticity (Bayer et al., 2001; Guetg et al., 2010; El
Gaamouch et al., 2012). Unlike the earlier examples of indirect
receptor modulation, AKAPs and other signaling molecules like
CaMKII potentially function as direct links between glutamate
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and GABAB receptors. If further characterized these complexes
may eventually serve as potential drug targets.
Conclusions
Taken together we can conclude that there is very tight
regulation between glutamate and GABAB receptors. Regulation
of NMDAR-mediated synaptic signals by GABABRs comprises
a powerful mechanism for controlling the major excitatory
systems in brain. Conversely, NMDAR-mediated control of
GABABRs is clearly an important emerging concept in dictating
the balance of excitability in the brain. Studying the trafficking
and signaling pathways utilized by these excitatory and inhibitory
receptors in an integrated manner will undoubtedly provide
more understanding of these critical regulatory mechanisms
and will ultimately shed light on how the balance between
excitatory and inhibitory neurotransmission is dictated in the
brain. While many examples of interactions between glutamate
and GABAB receptors have been discovered, importantly, the
molecular players involved in mediating this cross-talk are only
just beginning to be discovered. With this in mind, investigation
of the potential players in these processes, such as the AKAPs,
is an exciting future avenue of study. Ultimately, targeting
these specific regulatory pathways may form the basis of new
therapies to treat a number of neurological disorders that
are characterized by aberrant balance between excitatory and
inhibitory neurotransmitter systems in the brain.
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